INTERFERON-γ INDUCIBLE PROTEIN-10 (IP-10) IS A UNIQUE CYTOKINE PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE TO PEGINTERFERON AND RIBAVIRIN IN AFRICAN AMERICAN AND CAUCASIAN AMERICAN PATIENTS WITH CHRONIC HEPATITIS C

被引:0
|
作者
Fried, Michael W. [1 ]
Howell, Charles D. [2 ]
Hudson, Michael L. [1 ]
Bollekens, Jacques [3 ]
Aerssens, Jeroen [3 ]
De Wit, Mieke [3 ]
Scholliers, Annick [3 ]
Fanning, Gregory [3 ]
机构
[1] Univ N Carolina, Chapel Hill, NC 27514 USA
[2] Univ Maryland, Baltimore, MD 21201 USA
[3] Tibotec, Mechelen, Belgium
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1223
引用
收藏
页码:852A / 853A
页数:2
相关论文
共 50 条
  • [1] Interferon-γ-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features & sustained virological response
    Crisan, Dana
    Grigorescu, Mircea Dan
    Radu, Corina
    Suciu, Alina
    Grigorescu, Mircea
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 145 : 543 - 550
  • [2] INTERFERON-γ INDUCIBLE PROTEIN-10 (IP-10) IS A PREDICTOR OF OUTCOME DURING THE ACUTE PHASE OF HCV INFECTION
    Chokshi, S.
    Guobuzaite, A.
    Riva, A.
    Evans, A.
    Phillips, S.
    Ambrozaitis, A.
    Naoumov, N.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S135 - S135
  • [3] Association of pretreatment serum interferon γ inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C
    Diago, M
    Castellano, G
    García-Samaniego, J
    Pérez, C
    Fernández, I
    Romero, M
    Iacono, OL
    García-Monzón, C
    [J]. GUT, 2006, 55 (03) : 374 - 379
  • [4] Association of Interferon-γ Inducible Protein-10 Pretreatment Level and Sustained Virological Response in HCV-Positive Egyptian Patients
    Omran, Dalia
    Hamdy, Sherif
    Tawfik, Salwa
    Esmat, Serag
    Saleh, Doa'a A.
    Zayed, Rania A.
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2014, 44 (02): : 167 - 172
  • [5] Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection
    Grebely, Jason
    Feld, Jordan J.
    Applegate, Tanya
    Matthews, Gail V.
    Hellard, Margaret
    Sherker, Alana
    Petoumenos, Kathy
    Zang, Geng
    Shaw, Ineke
    Yeung, Barbara
    George, Jacob
    Teutsch, Suzy
    Kaldor, John M.
    Cherepanov, Vera
    Bruneau, Julie
    Shoukry, Naglaa H.
    Lloyd, Andrew R.
    Dore, Gregory J.
    [J]. HEPATOLOGY, 2013, 57 (06) : 2124 - 2134
  • [6] HCV-specific production of IL-10 and IFN-gamma-inducible protein-10 (IP-10) levels predict treatment response to pegylated interferon and ribavirin in children with chronic hepatitis C infection
    Carey, Ivana
    Mytilinaiou, Maria
    Hussain, Munther
    Bansal, Sanjay
    Subramaniam, Pushpa
    Horner, Mary
    Longhi, Maria Serena
    Meda, Francesca
    Mieli-Vergani, Giorgina
    Vergani, Diego
    [J]. HEPATOLOGY, 2007, 46 (04) : 279A - 279A
  • [7] The clinical significance of interferon inducible protein-10 in chronic hepatitis C patients with genotype I undergoing pegylated interferon and ribavirin therapy
    Kim, Chung Ho
    Kim, Ji Hoon
    Jong, Young Kul
    Kim, Jeong Han
    Choi, Jong Hwan
    Hong, Seong Kweon
    Ju, Moon Kyung
    Lee, Beom Jae
    Yim, Hyung Joon
    Yeon, Jong Eun
    Park, Jong-Jae
    Kim, Jae Seon
    Bak, Young Tae
    Byun, Kwan Soo
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A42 - A42
  • [8] The pharmacokinetics of peginterferon alfa-2a and ribavirin in African American, Hispanic and Caucasian patients with chronic hepatitis C
    Brennan, B. J.
    Morcos, P. N.
    Wang, K.
    Blotner, S. D.
    Morrison, R.
    Hagedorn, C. H.
    Marbury, T. C.
    Sulkowski, M.
    Grippo, J. F.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (10) : 1209 - 1220
  • [9] Peginterferon alfa-2a and ribavirin in African American and Caucasian patients with chronic hepatitis C, genotype 1
    Conjeevaram, HS
    Fried, MW
    Jeffers, LJ
    Terrault, N
    Wiley-Lucas, TE
    Afdhal, N
    Brown, RS
    Belle, SH
    Robuck, PR
    Howell, CD
    [J]. HEPATOLOGY, 2005, 42 (04) : 275A - 276A
  • [10] Pretreatment serum interferon gamma inducible protein-10 as biomarker of fibrosis and predictor of virological response in genotype 4 hepatitis C virus infection
    Khalifa, K. A.
    Radwan, W. M.
    Attallah, K. M.
    Hosney, H.
    Eed, E. M.
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2014, 77 (04): : 401 - 407